Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.775
+0.055 (3.20%)
At close: Sep 17, 2026, 4:00 PM EDT
1.780
+0.005 (0.28%)
After-hours: Sep 17, 2026, 4:04 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $77.47 million as of September 17, 2026. Its market cap has increased by 32.21% in one year.
Market Cap
77.47M
Enterprise Value
64.99M
1-Year Change
32.21%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $77.47M, a decrease of -37.85%. That is a compound annual growth rate of -8.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 77.47M | -37.45% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 78.85M |
| Kalaris Therapeutics | 77.60M |
| RenovoRx | 76.04M |
| iBio, Inc. | 75.88M |
| Cingulate | 74.16M |
| Connect Biopharma Holdings | 73.68M |
| NeurAxis | 71.70M |
| OKYO Pharma | 71.37M |